John S. Montalbano, Director at AbCellera Biologics Inc. (ABCL), bought 30,000 shares at $4.64 ($137K) on 2023-11-06, disclosed to the SEC on 2023-11-08.
Open-market purchase of $137k ABCL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 20,000 | $93K | 67.5% |
| 2 | $4.46 | 10,000 | $45K | 32.5% |
| Total | $4.58 avg | 30,000 | $137K | 100% |
| Filing → |
| ABCL | BUY | 2025-11-26 | $179K | — | Filing → |
| ABCL | BUY | 2025-03-10 | $115K | — | Filing → |
| ABCL | BUY | 2025-03-07 | $140K | — | Filing → |